Sickle Cell Anemia in an Arab Bedouin Village in the Jezreel Valley

This study is not yet open for participant recruitment.

Verified by HaEmek Medical Center, Israel, April 2007

First Received: May 31, 2007 No Changes Posted

Sponsored by:	HaEmek Medical Center, Israel
Information provided by:	HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:	NCT00481039

Purpose

Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel. The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.

Condition	Intervention
Sickle Cell Disease	Procedure: Medical history and basic laboratory analysis

Genetics Home Reference related topics: beta thalassemia sickle cell disease

MedlinePlus related topics: Anemia Sickle Cell Anemia Thalassemia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Cross-Sectional, Defined Population, Retrospective/Prospective Study
Official Title:	Sickle Cell Anemia in an Arab Bedouin Village in the Jezreel Valley - An Observational Study

Further study details as provided by HaEmek Medical Center, Israel:

Study Start Date:

May 2007

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

All the patients that were diagnosed as having sickle cell disease in the specific village and all the population screened for hemoglobinopathies in the same location

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00481039

Contacts

Contact: Ariel Koren, MD

972-4-6495576 ext 5576

koren_a@clalit.org.il

Locations

Israel
Pediatric Hematology Unit - HaEmek Medical Center
Afula, Israel, 18101

Sponsors and Collaborators

HaEmek Medical Center, Israel

Investigators

Study Director:	Ariel Koren, MD	Pediatric Hematology Unit, Ha'Emek Medical Center
Study Chair:	luci Zalman, Phd	Hematology Laboratory - HaEmek Medical Center
Principal Investigator:	Tania Flaishman, Student	Pediatric Dpt B - Ha'Emek Medical Center

More Information

No publications provided

Study ID Numbers:	5311006.EMC
Study First Received:	May 31, 2007
Last Updated:	May 31, 2007
ClinicalTrials.gov Identifier:	NCT00481039 History of Changes
Health Authority:	Israel: Ministry of Health

Keywords provided by HaEmek Medical Center, Israel:

Sickle cell disease
Sickle cell thalassemia
Population screening

Study placed in the following topic categories:

Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Anemia

Sickle Cell Anemia
Anemia, Hemolytic
Hemoglobinopathy
Thalassemia
Anemia, Sickle Cell

Additional relevant MeSH terms:

Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies

Anemia
Anemia, Hemolytic
Anemia, Sickle Cell

ClinicalTrials.gov processed this record on May 07, 2009